Preferences and perceptions of 617 migraine patients on acute and preventive migraine treatment attributes and clinical trial endpoints.
Vikelis M, Rikos D, Argyriou AA, Papachristou P, Rallis D, Karapanayiotides T, Galanopoulos A, Spingos K, Dimisianos N, Giakoumakis E, Zavridis P, Notas K, Vlachos GS, Soldatos P, Bilias K, Xiromerisiou G, Rudolf J, Dermitzakis EV, Rapoport AM.
Vikelis M, et al. Among authors: rudolf j.
Expert Rev Neurother. 2024 Jun 13:1-12. doi: 10.1080/14737175.2024.2365312. Online ahead of print.
Expert Rev Neurother. 2024.
PMID: 38870024